EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Jacalin-Curcumin Complex Sensitizes the Breast Cancer MDA-MB-231 Cell Line

Lidiya Petrova, Nikolay Gergov iD, Marie Stoup, Silvina Zapryanova iD, Els J M Van Damme iD, Nicolas Lebègue iD, Maxime Liberelle, Diana Zasheva, Vanya Bogoeva

International Journal of Molecular Sciences · 12.12.2023 · 24 (24) · 17399

DOI: 10.3390/ijms242417399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.12.2023. Verfasst von Lidiya Petrova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Medical University-Pleven, "St. Kliment Ohridski" Str. 1, 5800 Pleven, Bulgaria. Hauptthemen laut MEDLINE: Curcumin, Breast Neoplasms, Triple Negative Breast Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medicla university, Pleven Bulgarian National Science Fund, Bulgarian National Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein–drug interactions are crucial for understanding drug delivery and cell functions. Jacalin is a suitable molecule for such targeting, as it specifically recognizes the tumor-associated Thomsen–Friedenreich (TF) antigen that is expressed on the glycosylated proteins in cancer cells. The present paper describes the interaction of curcumin and jacalin, a possible carrier molecule for the delivery of antitumor drugs due to its ability to recognize tumor cells. Our results have shown that both steady-state fluorescence and fluorescent labelling of jacalin are two reliable methods to determine jacalin-curcumin interactions. The affinity of jacalin for curcumin is consistently within the micromolar range (using fluorescence and microscale thermophoresis) showing high-affinity binding of the complex. In vitro experiments on triple-negative breast cancer MDA-MB-231 cells indicated inhibition of cell growth after treating with the jacalin-curcumin complex for 48 h. The cell survival fraction was significantly reduced to 50% after combined treatment. In this paper, we report for the first time about the jacalin-curcumin interaction. We quantified this unique biomolecular interaction and gathered additional information on the binding event. We observed that the jacalin-curcumin complex inhibits the proliferation of the triple-negative breast cancer MDA-MB-231 cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminBreast NeoplasmsTriple Negative Breast NeoplasmsAntineoplastic AgentsHumansFemaleMDA-MB-231 CellsCell ProliferationAntigens, NeoplasmCell Line, TumorApoptosisPlant Lectins

Stichwörter der Autor:innen

MDA-MB-231breast cancer cellscurcumincytotoxicityfluorescencejacalinprotein–ligand interaction

Substanzen

CurcuminAntineoplastic AgentsAntigens, NeoplasmjacalinPlant Lectins

Autor:innen und Institutionen

  • Department of Biology, Medical University-Pleven, "St. Kliment Ohridski" Str. 1, 5800 Pleven, Bulgaria.
  • Institute of Molecular Biology "Rumen Tzanev", Bulgarian Academy of Sciences, "Acad. George Bonchev" Str., Bl. 21, 1113 Sofia, Bulgaria.
  • School of Pharmacy, University Lille, Inserm, CHU Lille, UMR-S 1172-LiNC-Lille Neuroscience and Cognition, F-59000 Lille, France.
  • Institute of Biology and Immunology of Reproduction, Bulgarian Academy of Sciences, Tsarigradsko Shosse, 73, 1113 Sofia, Bulgaria.
  • Department Biotechnology, Ghent University, Proeftuinstraat 86, 9000 Gent, Belgium.

ORCID-Profile: Nikolay Gergov, Silvina Zapryanova, Els J M Van Damme, Nicolas Lebègue

Förderung

  • Medicla university, Pleven Bulgarian National Science Fund
  • Bulgarian National Science Fund

Zitieren

APA

Petrova, L., Gergov, N., Stoup, M., Zapryanova, S., Van Damme, E. J. M., Lebègue, N., Liberelle, M., Zasheva, D., & Bogoeva, V. (2023). Jacalin-Curcumin Complex Sensitizes the Breast Cancer MDA-MB-231 Cell Line. International Journal of Molecular Sciences, 24(24), 17399. https://doi.org/10.3390/ijms242417399

Vancouver

Petrova L, Gergov N, Stoup M, Zapryanova S, Van Damme EJM, Lebègue N, et al. Jacalin-Curcumin Complex Sensitizes the Breast Cancer MDA-MB-231 Cell Line. International Journal of Molecular Sciences. 2023;24(24):17399. doi:10.3390/ijms242417399

BibTeX
@article{Petrova2023,
  author = {Petrova, Lidiya and Gergov, Nikolay and Stoup, Marie and Zapryanova, Silvina and Van Damme, Els J M and Lebègue, Nicolas and Liberelle, Maxime and Zasheva, Diana and Bogoeva, Vanya},
  title = {Jacalin-Curcumin Complex Sensitizes the Breast Cancer MDA-MB-231 Cell Line},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {24},
  pages = {17399},
  doi = {10.3390/ijms242417399}
}
Kostenlos starten →